Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.551
+0.011 (1.96%)
Nov 21, 2024, 1:10 PM EST - Market open

MTNB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
-1.13.190.030.160.09
Upgrade
Revenue Growth (YoY)
--65.62%9560.61%-79.16%76.29%-25.00%
Upgrade
Cost of Revenue
14.4914.4916.6814.5814.3611.23
Upgrade
Gross Profit
-14.49-13.39-13.49-14.55-14.2-11.14
Upgrade
Selling, General & Admin
9.2910.3711.110.1910.017.78
Upgrade
Research & Development
-1.77-----
Upgrade
Operating Expenses
7.5210.3711.110.1910.017.78
Upgrade
Operating Income
-22.01-23.77-24.59-24.74-24.21-18.92
Upgrade
Interest Expense
-0-0-0-0-0.01-0.01
Upgrade
Other Non Operating Income (Expenses)
0.880.833.591.461.761.56
Upgrade
EBT Excluding Unusual Items
-21.13-22.94-21-23.28-22.46-17.37
Upgrade
Gain (Loss) on Sale of Investments
----0.01-
Upgrade
Pretax Income
-21.13-22.94-21-23.28-22.45-17.37
Upgrade
Net Income
-21.13-22.94-21-23.28-22.45-17.37
Upgrade
Preferred Dividends & Other Adjustments
---0.40.790.92
Upgrade
Net Income to Common
-21.13-22.94-21-23.68-23.24-18.3
Upgrade
Shares Outstanding (Basic)
544443
Upgrade
Shares Outstanding (Diluted)
544443
Upgrade
Shares Change (YoY)
7.93%0.21%3.16%6.75%35.61%48.00%
Upgrade
EPS (Basic)
-4.52-5.28-4.84-5.63-5.90-6.30
Upgrade
EPS (Diluted)
-4.52-5.28-4.84-5.63-5.90-6.30
Upgrade
Free Cash Flow
-16.95-15.5-20.05-15.48-17.37-14.5
Upgrade
Free Cash Flow Per Share
-3.62-3.57-4.62-3.68-4.41-4.99
Upgrade
Operating Margin
--2168.43%-771.33%-74954.55%-15288.38%-21067.38%
Upgrade
Profit Margin
--2093.25%-658.63%-71754.55%-14678.10%-20372.35%
Upgrade
Free Cash Flow Margin
--1413.87%-628.86%-46918.18%-10972.81%-16142.24%
Upgrade
EBITDA
-21.63-23.37-24.23-24.46-23.92-18.59
Upgrade
D&A For EBITDA
0.380.390.360.280.290.33
Upgrade
EBIT
-22.01-23.77-24.59-24.74-24.21-18.92
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.